itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens (vol 66, 103288, 2021)

被引：0

作者：

Liesenborghs, Laurens ^{[1
,2
]}

Spriet, Isabel ^{[3
,4
]}

Jochmans, Dirk ^{[1
]}

Belmans, Ann ^{[5
,6
]}

Gyselinck, Iwein ^{[7
,8
]}

Teuwen, Laure-Anne ^{[9
]}

ter Horst, Sebastiaan ^{[1
]}

Dreesen, Erwin ^{[10
]}

Geukens, Tatjana ^{[11
]}

Engelen, Matthias M. ^{[12
,13
]}

Landeloos, Ewout ^{[14
]}

Geldhof, Vincent ^{[9
]}

Ceunen, Helga ^{[15
,16
]}

Debaveye, Barbara ^{[12
,13
]}

Vandenberk, Bert ^{[12
,13
]}

Van der Linden, Lorenz ^{[3
,4
]}

Jacobs, Sofie ^{[1
]}

Langendries, Lana ^{[1
]}

Boudewijns, Robbert ^{[1
]}

Do, Thuc Nguyen Dan ^{[1
]}

Chiu, Winston ^{[1
]}

Wang, Xinyu ^{[1
]}

Zhang, Xin ^{[1
]}

Weynand, Birgit ^{[17
]}

Vanassche, Thomas ^{[12
,13
]}

Devos, Timothy ^{[18
,19
]}

Meyfroidt, Geert ^{[13
,20
]}

Janssens, Wim ^{[7
,8
]}

Vos, Robin ^{[7
,8
]}

Vermeersch, Pieter ^{[21
,22
]}

Wauters, Joost ^{[16
,23
]}

Verbeke, Geert ^{[5
,6
]}

De Munter, Paul ^{[15
,16
]}

Kaptein, Suzanne J. F. ^{[1
]}

Rocha-Pereira, Joana ^{[1
]}

Delang, Leen ^{[1
]}

Van Wijngaerden, Eric ^{[15
,16
]}

Neyts, Johan ^{[1
]}

Verhamme, Peter ^{[12
,13
]}

机构：

[1] Katholieke Univ Leuven, Lab Virol & Chemotherapy, Dept Microbiol Immunol & Transplantat, Rega Inst Med Res, Leuven, Belgium

[2] Inst Trop Med, Outbreak Res Team, Dept Clin Sci, Antwerp, Belgium

[3] Katholieke Univ Leuven, Pharm Dept Univ Hosp Leuven, Leuven, Belgium

[4] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium

[5] KU Leuven Univ Leuven, Leuven, Belgium

[6] Univ Hasselt, I BioStat, Leuven, Belgium

[7] Katholieke Univ Leuven, Dept Resp Dis, UZ Leuven, Leuven, Belgium

[8] Katholieke Univ Leuven, CHROMETA, Res Grp BREATHE, Leuven, Belgium

[9] Katholieke Univ Leuven, Lab Angiogenesis & Vasc Metab, Ctr Canc Biol, VIB,Dept Oncol,Leuven Canc Inst, Leuven, Belgium

[10] Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy Unit, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium

[11] Katholieke Univ Leuven, Dept Oncol, Lab Translat Breast Canc Res, Leuven, Belgium

[12] UZ, Dept Cardiovasc Sci, Leuven, Belgium

[13] Katholieke Univ Leuven, Leuven, Belgium

[14] VIB KU Leuven, Dept Oncol, Lab Mol Canc Biol, Leuven, Belgium

[15] Katholieke Univ Leuven, Dept Gen Internal Med, UZ Leuven, Leuven, Belgium

[16] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium

[17] Katholieke Univ Leuven, Translat Cell & Tissue Res, Dept Imaging & Pathol, Leuven, Belgium

[18] Katholieke Univ Leuven, Dept Hematol, UZ Leuven, Leuven, Belgium

[19] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Lab Mol Immunol, Rega Inst, Leuven, Belgium

[20] UZ, Dept & Lab Intens Care Med, Leuven, Belgium

[21] Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium

[22] Katholieke Univ Leuven, Dept Clin Lab Med, Leuven, Belgium

[23] Katholieke Univ Leuven, Med Intens Care Unit, Leuven, Belgium

来源：

EBIOMEDICINE | 2021年 / 69卷

基金：

欧盟地平线“2020”;

关键词：

D O I：

10.1016/j.ebiom.2021.103454

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：1

共 50 条

[1] Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial
Liesenborghs, Laurens
Spriet, Isabel
Jochmans, Dirk
Belmans, Ann
Gyselinck, Iwein
Teuwen, Laure-Anne
ter Horst, Sebastiaan
Dreesen, Erwin
Geukens, Tatjana
Engelen, Matthias M.
Landeloos, Ewout
Geldhof, Vincent
Ceunen, Helga
Debaveye, Barbara
Vandenberk, Bert
van der Linden, Lorenz
Jacobs, Sofie
Langendries, Lana
Boudewijns, Robbert
Do, Thuc Nguyen Dan
Chiu, Winston
Wang, Xinyu
Zhang, Xin
Weynand, Birgit
Vanassche, Thomas
Devos, Timothy
Meyfroidt, Geert
Janssens, Wim
Vos, Robin
Vermeersch, Pieter
Wauters, Joost
Verbeke, Geert
De Munter, Paul
Kaptein, Suzanne J. F.
Rocha-Pereira, Joana
Delang, Leen
Van Wijngaerden, Eric
Neyts, Johan
Verhamme, Peter
EBIOMEDICINE, 2021, 66
[2] Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial (vol 37, 100,959, 2021)
Krolewiecki, Alejandro
Lifschitz, Adrian
Moragas, Matias
Travacio, Marina
Valentini, Ricardo
Alonso, Daniel F.
Solari, Ruben
Tinelli, Marcelo A.
Cimino, Ruben O.
Alvarez, Luis
Fleitas, Pedro E.
Ceballos, Laura
Golemba, Marcelo
Fernandez, Florencia
de Oliveira, Diego Fernandez
Astudillo, German
Baeck, Ines
Farina, Javier
Cardama, Georgina A.
Mangano, Andrea
Spitzer, Eduardo
Gold, Silvia
Lanusse, Carlos
ECLINICALMEDICINE, 2021, 39
[3] The effects of urine alkalinization on kidney function in critically ill patients with COVID-19: a proof-of-concept randomized clinical trial
Lumlertgul, Nuttha
Kellum, John A.
Powell-Tuck, Jonah
Mathew, Moncy
Sardiwal, Sunita
Ostermann, Marlies
INTENSIVE CARE MEDICINE EXPERIMENTAL, 2025, 13 (01):
[4] Machine learning is the key to diagnose COVID-19: a proof-of-concept study (vol 11, 7166, 2021)
Gangloff, Cedric
Rafi, Sonia
Bouzille, Guillaume
Soulat, Louis
Cuggia, Marc
SCIENTIFIC REPORTS, 2021, 11 (01)
[5] Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial
Krolewiecki, Alejandro
Lifschitz, Adrian
Moragas, Matias
Travacio, Marina
Valentini, Ricardo
Alonso, Daniel F.
Solari, Ruben
Tinelli, Marcelo A.
Cimino, Ruben O.
Alvarez, Luis
Fleitas, Pedro E.
Ceballos, Laura
Golemba, Marcelo
Fernandez, Florencia
de Oliveira, Diego Fernandez
Astudillo, German
Baeck, Ines
Farina, Javier
Cardama, Georgina A.
Mangano, Andrea
Spitzer, Eduardo
Gold, Silvia
Lanusse, Carlos
ECLINICALMEDICINE, 2021, 37
[6] US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19
Finberg, Robert W.
Ashraf, Madiha
Julg, Boris
Ayoade, Folusakin
Marathe, Jai G.
Issa, Nicolas C.
Wang, Jennifer P.
Jaijakul, Siraya
Baden, Lindsey R.
Epstein, Carol
OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (12):
[7] Effectiveness of a Videoconferencing-Delivered Psychological Intervention for Mental Health Problems during COVID-19: A Proof-of-Concept Randomized Clinical Trial
Bryant, Richard A.
Dawson, Katie S.
Keyan, Dharani
Azevedo, Suzanna
Yadav, Srishti
Tran, Jenny
Rawson, Natasha
Harvey, Samuel
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2022, 91 (01) : 63 - 72
[8] Machine learning is the key to diagnose COVID-19: a proof-of-concept study
Cedric Gangloff
Sonia Rafi
Guillaume Bouzillé
Louis Soulat
Marc Cuggia
Scientific Reports, 11
[9] Positive affect training to reduce mental health problems during the COVID-19 pandemic: a proof-of-concept randomised clinical trial
Bryant, Richard
Dawson, Katie
Azevedo, Suzanna
Yadav, Srishti
Tran, Jenny
Choi-Christou, Jasmine
Andrew, Elpiniki
Beames, Joanne
Keyan, Dharani
BMJ MENTAL HEALTH, 2023, 26 (01):
[10] A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study
T. Vanassche
M. M. Engelen
Q. Van Thillo
J. Wauters
J. Gunst
C. Wouters
C. Vandenbriele
S. Rex
L. Liesenborghs
A. Wilmer
P. Meersseman
G. Van den Berghe
D. Dauwe
G. Verbeke
M. Thomeer
T. Fivez
D. Mesotten
D. Ruttens
L. Heytens
I. Dapper
S. Tuyls
B. De Tavernier
P. Verhamme
Trials, 21

← 1 2 3 4 5 →